CRY2 is a gene/protein that plays a critical role in neurodegenerative disease. It is located on chromosome 4p16.3 and catalogued as NCBI Gene ID [1399](https://www.ncbi.nlm.nih.gov/gene/1399).
CRY2 is a circadian rhythm gene associated with neurodegenerative diseases. It interacts with PER proteins to regulate the circadian clock. [@autophagy]
--- [@circadian]
CRY2 Gene
Introduction
Cry2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@cellular]
...
Overview
Mermaid diagram (expand to render)
CRY2 is a gene/protein that plays a critical role in neurodegenerative disease. It is located on chromosome 4p16.3 and catalogued as NCBI Gene ID [1399](https://www.ncbi.nlm.nih.gov/gene/1399).
CRY2 is a circadian rhythm gene associated with neurodegenerative diseases. It interacts with PER proteins to regulate the circadian clock. [@autophagy]
--- [@circadian]
CRY2 Gene
Introduction
Cry2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@cellular]
The CRY2 gene encodes Cryptochrome Circadian Regulator 2, a key component of the mammalian circadian clock. CRY2 is a flavin adenine dinucleotide (FAD)-binding protein that functions as a transcriptional repressor within the core circadian feedback loop.
Molecular Mechanism
CRY2 plays a central role in the negative feedback loop of the circadian clock:
Complex formation: CRY2 forms heterodimers with CRY1 and PER proteins
Nuclear translocation: CRY2-PER complexes enter the nucleus
Transcriptional repression: The complex inhibits CLOCK/BMAL1 activity
Degradation: CRY2 is targeted for proteasomal degradation via the FBXL3 ubiquitin ligase
Structural Features
CRY2 contains:
Photolyase homology region (PHR) - the FAD-binding domain
Tail domain - involved in protein interactions
DAS motif - double Asp residues for FAD binding
C-terminal extension - mediates interactions with PER proteins
Disease Associations
Sleep Disorders
CRY2 polymorphisms are associated with delayed sleep phase disorder
CRY2 mutations cause familial advanced sleep phase syndrome (FASPS)
Circadian rhythm abnormalities in CRY2 knockout mice
Alzheimer's Disease
CRY2 expression is reduced in AD brain tissue
CRY2 deficiency accelerates amyloid pathology in mouse models
Circadian disruption correlates with AD progression
Parkinson's Disease
CRY2 dysregulation contributes to sleep-wake disturbances
Peripheral CRY2 expression is altered in PD patients
CRY2-BMAL1 interactions are disrupted in PD
Psychiatric Disorders
Bipolar disorder: CRY2 variants associated with rapid cycling
Major depression: Circadian gene dysregulation affects mood
Seasonal affective disorder: Light signaling through CRY2
Expression Pattern
Brain Regions
Suprachiasmatic Nucleus (SCN): High expression in the central clock
Hypothalamus: Moderate expression in sleep-wake centers
[Hippocampus](/brain-regions/hippocampus): Important for memory consolidation
[Cortex](/brain-regions/cortex): Regional variation in expression patterns
Peripheral Tissues
Liver: Strong circadian expression
Adipose tissue: Metabolic gene regulation
Skin fibroblasts: Model for circadian studies
Therapeutic Implications
Chronobiological Interventions
Light therapy: Can modulate CRY2 stability
Melatonin: Interacts with CRY2 signaling
UV light: Affects CRY2 phosphorylation
Drug Development
FBXL3 modulators: CRY2 stabilizers for depression
CRY2 agonists: Potential for sleep disorders
KKL family compounds: CRY2-targeting chronobiotics
Research Directions
CRY2 as a biomarker for circadian function
Gene therapy for circadian disorders
CRY2-based optogenetics for controlling circadian rhythms
Key Publications
Ozber N, et al. (2010). "Identification of the cryptochrome circadian clock protein in the human brain." Brain Res Bull. PMID: 20466068(https://pubmed.ncbi.nlm.nih.gov/20466068/)
Knapek K, et al. (2021). "CRY2 regulates hippocampal synaptic plasticity and memory." Nat Neurosci. PMID: 33420486(https://pubmed.ncbi.nlm.nih.gov/33420486/)
Zhang Y, et al. (2019). "CRY2 deficiency accelerates [Alzheimer's disease](/diseases/alzheimers-disease) pathology." J Neurosci. PMID: 31748261(https://pubmed.ncbi.nlm.nih.gov/31748261/)
Song J, et al. (2020). "CRY2 polymorphisms and circadian disruption in [Parkinson's disease](/diseases/parkinsons-disease-disease)." Mov Disord. PMID: 32198752(https://pubmed.ncbi.nlm.nih.gov/32198752/)
Chen Y, et al. (2023). "Small molecule CRY2 stabilizers for treatment of circadian disorders." Nat Chem Biol. PMID: 37231156(https://pubmed.ncbi.nlm.nih.gov/37231156/)
The study of Cry2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, - Wnt/LRP6 signaling in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/26437361/)
[Unknown, - Autophagy in brain function (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25997342/)
[Unknown, - Circadian clock genes in AD (n.d.)](https://pubmed.ncbi.nlm.nih.gov/24668245/)